eMERGE HGSC-Clinical Laboratory

The Electronic Medical Records and Genomics (eMERGE) Phase III program of the National Institutes of Health aims to develop and validate electronic phenotyping algorithms for large-scale, high-throughput genomics research; to discover genetic variants related to complex traits; to disseminate results and lessons learned to the scientific community; and to deliver state-of-the-art genomic knowledge, methods, and approaches to clinical decision support and clinical care.

eMERGE III consists of nine study sites, two central sequencing and genotyping facilities and a coordinating center. This portal is for sample uploads from sites served by the Human Genome Sequencing Center-Clinical Laboratory (HGSC-CL) and serves as a gateway to all data housed in the eMERGE Data Commons.

Investigators at external institutions may apply for affiliate membership to the eMERGE Network. Information about affiliate membership such as benefits, criteria for participation, and application process can be found at the eMERGE webpage.


  February 3, 2023
The eMERGE (electronic MEdical Records and GEnomics) Network was organized and funded by the National Human Genomic Research Institute (NHGRI) in ...
  April 13, 2021
She is a principal investigator in the eMERGE (electronic Medical Records and Genomics) Network, which aims to integrate polygenic risk information ...
  June 19, 2020
NEW YORK – Investigators involved in the third phase of the Electronic Medical Records and Genomics Network (EMERGE III) have tracked the ...
  April 30, 2020
... the electronic Medical Records and Genomics Network (eMERGE) and BioVU at Vanderbilt University, to identify and analyze novel, genome-wide ...